IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
| Status: | Archived |
|---|---|
| Conditions: | Breast Cancer, Lung Cancer, Skin Cancer, Cancer, Cancer, Pancreatic Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | August 2008 |
| End Date: | March 2010 |
A Phase I Study of 1-methyl-D-tryptophan (D-1MT) in Patients With Relapsed or Refractory Solid Tumors
This study provides an early evaluation of an entirely new class of small molecule agents
directed at disruption or elimination of tumor tolerance, a phenomenon now demonstrated to
be involved in the growth of many solid tumors.
We found this trial at
1
site
Click here to add this to my saved trials
